TECTONIC THERAPEUTIC, INC. Earnings Per Share, Basic and Diluted
TECTONIC THERAPEUTIC, INC. (TECX) reported Earnings Per Share, Basic and Diluted of -$0.68 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-10
- TECTONIC THERAPEUTIC, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.68.
- TECTONIC THERAPEUTIC, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.75.
- TECTONIC THERAPEUTIC, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.74.
- TECTONIC THERAPEUTIC, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.65.
- TECTONIC THERAPEUTIC, INC. earnings per share, basic and diluted for fiscal 2021 was -$2.78.
- TECTONIC THERAPEUTIC, INC. earnings per share, basic and diluted for fiscal 2020 was -$3.31.
- TECTONIC THERAPEUTIC, INC. earnings per share, basic and diluted for fiscal 2019 was -$2.66.
- TECTONIC THERAPEUTIC, INC. earnings per share, basic and diluted for fiscal 2018 was -$3.62.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.68 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | -$2.78 10-K · filed 2022-03-17 | |||
| 2021-09-30 | -$0.75 10-Q · filed 2021-11-04 | -$2.13 10-Q · filed 2021-11-04 | ||
| 2021-06-30 | -$0.74 10-Q · filed 2021-08-05 | -$1.39 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | -$0.65 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$3.31 10-K · filed 2022-03-17 | |||
| 2020-09-30 | -$1.01 10-Q · filed 2021-11-04 | -$2.59 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | -$0.80 10-Q · filed 2021-08-05 | -$1.57 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$0.77 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$2.66 10-K · filed 2021-03-18 | |||
| 2019-09-30 | -$0.57 10-Q · filed 2020-11-05 | -$1.93 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | -$0.67 10-Q · filed 2020-08-06 | -$1.38 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | -$0.72 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | -$3.62 10-K · filed 2020-03-16 | |||
| 2018-09-30 | -$0.49 10-Q · filed 2019-11-07 | -$3.28 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | -$2.98 10-Q · filed 2019-08-08 | -$7.16 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | -$4.51 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | -$8.38 10-K · filed 2019-03-25 | |||
| 2017-09-30 | -$2.85 10-Q · filed 2018-11-13 | -$5.01 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | -$1.15 10-Q · filed 2018-08-09 | -$2.12 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |